Detalhe da pesquisa
1.
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.
Cancer Res
; 76(5): 1225-36, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873845